Active	Status	Sponsor type	Region	Phase	Filter
15 Active 3 Inactive 18 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

15 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kong, Yaozhong
NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED )	Recruiting	4	9000	RoW	Aspirin 100 mg Oral Tablet, Matching Placebo	Guangdong Provincial People's Hospital, The George Institute	CKD (Chronic Kidney Disease) Stage 5D	09/26	12/26
Ye, Zhiming
NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED )	Recruiting	4	9000	RoW	Aspirin 100 mg Oral Tablet, Matching Placebo	Guangdong Provincial People's Hospital, The George Institute	CKD (Chronic Kidney Disease) Stage 5D	09/26	12/26
NCT06470191: A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.	Recruiting	2/3	216	RoW	B007, Cyclosporin Capsules	Shanghai Jiaolian Drug Research and Development Co., Ltd, Shanghai Pharmaceuticals Holding Co., Ltd	Primary Membranous Nephropathy	12/26	12/26
NCT05810948: A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Lupus Nephritis (ZL-1103-013)	Active, not recruiting	2	73	RoW	efgartigimod IV, Placebo	argenx, Zai Lab (Shanghai) Co., Ltd.	Lupus Nephritis	07/25	09/25
PALIZADE, NCT05781750: A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis	Suspended	2	279	Europe, US, RoW	zetomipzomib, KZR-616, placebo, matching placebo	Kezar Life Sciences, Inc.	Lupus Nephritis	05/26	07/26
NCT06774664: A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases	Not yet recruiting	1/2	99	RoW	SCTC21C	Sinocelltech Ltd.	IgA Nephropathy	09/27	03/29
DKTAVG, NCT06503692: Scoring Balloon and High Pressure Balloon in the Treatment of Arteriovenous Graft Stenosis	Recruiting	N/A	140	RoW	DKutting PTA Scoring Balloon Dilatation Catheter, Scoring Balloon, Peripheral Balloon Catheter	DK Medical Technology (Suzhou) Co., Ltd.	Arteriovenous Graft Stenosis	12/26	12/26
NCT05190848: Correlation of Microbiome and Metabonomics With IgA Nephropathy	Recruiting	N/A	600	RoW		Guangdong Provincial People's Hospital	IgA Nephropathy	12/24	12/25
NCT05188885: A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases	Recruiting	N/A	90000	RoW		Guangdong Provincial People's Hospital	Chronic Kidney Disease	12/26	12/28
Jiang, Xia
NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED )	Recruiting	4	9000	RoW	Aspirin 100 mg Oral Tablet, Matching Placebo	Guangdong Provincial People's Hospital, The George Institute	CKD (Chronic Kidney Disease) Stage 5D	09/26	12/26
NCT04373967: Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes	Recruiting	3	424	RoW	Victoza®., Metformin Hydrochloride, TQZ2451	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Type 2 Diabetes	12/21	12/21
NCT05188885: A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases	Recruiting	N/A	90000	RoW		Guangdong Provincial People's Hospital	Chronic Kidney Disease	12/26	12/28
Ye, Guolin
TCTN, NCT02455141: Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer	Recruiting	3	970	RoW	Epirubicin plus Cyclophosphamide, EC, Taxanes, Taxanes plus Carboplatin	Shanghai Jiao Tong University School of Medicine	Breast Neoplasm	12/22	12/23
NCT02062489: Evaluation of Tamoxifen's Efficacy for ER/PR Negative,ER-beta Positive Operable Breast Cancer Patients	Recruiting	3	688	RoW	Tamoxifen, Nolvadex, Placebo	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Breast Cancer	05/25	05/26
SYSBTC-001, NCT04456855: Locoregional Surgery of the Primary Tumor in de Novo Stage IV Breast Cancer Patients	Recruiting	N/A	358	RoW	Locoregional surgery	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Sun Yat-sen University, First People's Hospital of Foshan	Breast Neoplasm Female, Surgery, Advanced Breast Cancer	10/20	07/21

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kong, Yaozhong
NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED )	Recruiting	4	9000	RoW	Aspirin 100 mg Oral Tablet, Matching Placebo	Guangdong Provincial People's Hospital, The George Institute	CKD (Chronic Kidney Disease) Stage 5D	09/26	12/26
Ye, Zhiming
NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED )	Recruiting	4	9000	RoW	Aspirin 100 mg Oral Tablet, Matching Placebo	Guangdong Provincial People's Hospital, The George Institute	CKD (Chronic Kidney Disease) Stage 5D	09/26	12/26
NCT06470191: A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.	Recruiting	2/3	216	RoW	B007, Cyclosporin Capsules	Shanghai Jiaolian Drug Research and Development Co., Ltd, Shanghai Pharmaceuticals Holding Co., Ltd	Primary Membranous Nephropathy	12/26	12/26
NCT05810948: A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Lupus Nephritis (ZL-1103-013)	Active, not recruiting	2	73	RoW	efgartigimod IV, Placebo	argenx, Zai Lab (Shanghai) Co., Ltd.	Lupus Nephritis	07/25	09/25
PALIZADE, NCT05781750: A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis	Suspended	2	279	Europe, US, RoW	zetomipzomib, KZR-616, placebo, matching placebo	Kezar Life Sciences, Inc.	Lupus Nephritis	05/26	07/26
NCT06774664: A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases	Not yet recruiting	1/2	99	RoW	SCTC21C	Sinocelltech Ltd.	IgA Nephropathy	09/27	03/29
DKTAVG, NCT06503692: Scoring Balloon and High Pressure Balloon in the Treatment of Arteriovenous Graft Stenosis	Recruiting	N/A	140	RoW	DKutting PTA Scoring Balloon Dilatation Catheter, Scoring Balloon, Peripheral Balloon Catheter	DK Medical Technology (Suzhou) Co., Ltd.	Arteriovenous Graft Stenosis	12/26	12/26
NCT05190848: Correlation of Microbiome and Metabonomics With IgA Nephropathy	Recruiting	N/A	600	RoW		Guangdong Provincial People's Hospital	IgA Nephropathy	12/24	12/25
NCT05188885: A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases	Recruiting	N/A	90000	RoW		Guangdong Provincial People's Hospital	Chronic Kidney Disease	12/26	12/28
Jiang, Xia
NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED )	Recruiting	4	9000	RoW	Aspirin 100 mg Oral Tablet, Matching Placebo	Guangdong Provincial People's Hospital, The George Institute	CKD (Chronic Kidney Disease) Stage 5D	09/26	12/26
NCT04373967: Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes	Recruiting	3	424	RoW	Victoza®., Metformin Hydrochloride, TQZ2451	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Type 2 Diabetes	12/21	12/21
NCT05188885: A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases	Recruiting	N/A	90000	RoW		Guangdong Provincial People's Hospital	Chronic Kidney Disease	12/26	12/28
Ye, Guolin
TCTN, NCT02455141: Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer	Recruiting	3	970	RoW	Epirubicin plus Cyclophosphamide, EC, Taxanes, Taxanes plus Carboplatin	Shanghai Jiao Tong University School of Medicine	Breast Neoplasm	12/22	12/23
NCT02062489: Evaluation of Tamoxifen's Efficacy for ER/PR Negative,ER-beta Positive Operable Breast Cancer Patients	Recruiting	3	688	RoW	Tamoxifen, Nolvadex, Placebo	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Breast Cancer	05/25	05/26
SYSBTC-001, NCT04456855: Locoregional Surgery of the Primary Tumor in de Novo Stage IV Breast Cancer Patients	Recruiting	N/A	358	RoW	Locoregional surgery	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Sun Yat-sen University, First People's Hospital of Foshan	Breast Neoplasm Female, Surgery, Advanced Breast Cancer	10/20	07/21